IBDEI21M ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,32608,1,3,0)
;;=3^Exudative AMD,Rt Eye
;;^UTILITY(U,$J,358.3,32608,1,4,0)
;;=4^H35.3210
;;^UTILITY(U,$J,358.3,32608,2)
;;=^5138520
;;^UTILITY(U,$J,358.3,32609,0)
;;=H35.3220^^128^1665^29
;;^UTILITY(U,$J,358.3,32609,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32609,1,3,0)
;;=3^Exudative AMD,Lt Eye
;;^UTILITY(U,$J,358.3,32609,1,4,0)
;;=4^H35.3220
;;^UTILITY(U,$J,358.3,32609,2)
;;=^5138524
;;^UTILITY(U,$J,358.3,32610,0)
;;=R51.^^128^1665^31
;;^UTILITY(U,$J,358.3,32610,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32610,1,3,0)
;;=3^Headache
;;^UTILITY(U,$J,358.3,32610,1,4,0)
;;=4^R51.
;;^UTILITY(U,$J,358.3,32610,2)
;;=^5019513
;;^UTILITY(U,$J,358.3,32611,0)
;;=H20.00^^128^1665^32
;;^UTILITY(U,$J,358.3,32611,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32611,1,3,0)
;;=3^Iridocyclitis,Acute/Subacute,Unspec
;;^UTILITY(U,$J,358.3,32611,1,4,0)
;;=4^H20.00
;;^UTILITY(U,$J,358.3,32611,2)
;;=^5005133
;;^UTILITY(U,$J,358.3,32612,0)
;;=H02.204^^128^1665^33
;;^UTILITY(U,$J,358.3,32612,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32612,1,3,0)
;;=3^Lagophthalmos,Unspec,Lt Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,32612,1,4,0)
;;=4^H02.204
;;^UTILITY(U,$J,358.3,32612,2)
;;=^5004330
;;^UTILITY(U,$J,358.3,32613,0)
;;=H02.201^^128^1665^34
;;^UTILITY(U,$J,358.3,32613,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32613,1,3,0)
;;=3^Lagophthalmos,Unspec,Rt Upper Eyelid,Unspec
;;^UTILITY(U,$J,358.3,32613,1,4,0)
;;=4^H02.201
;;^UTILITY(U,$J,358.3,32613,2)
;;=^5004327
;;^UTILITY(U,$J,358.3,32614,0)
;;=H40.053^^128^1665^35
;;^UTILITY(U,$J,358.3,32614,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32614,1,3,0)
;;=3^Ocular Hypertension,Bilateral
;;^UTILITY(U,$J,358.3,32614,1,4,0)
;;=4^H40.053
;;^UTILITY(U,$J,358.3,32614,2)
;;=^5005742
;;^UTILITY(U,$J,358.3,32615,0)
;;=H26.492^^128^1665^36
;;^UTILITY(U,$J,358.3,32615,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32615,1,3,0)
;;=3^PCO/Secondary Cataract,Lt Eye
;;^UTILITY(U,$J,358.3,32615,1,4,0)
;;=4^H26.492
;;^UTILITY(U,$J,358.3,32615,2)
;;=^5005359
;;^UTILITY(U,$J,358.3,32616,0)
;;=H26.491^^128^1665^37
;;^UTILITY(U,$J,358.3,32616,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32616,1,3,0)
;;=3^PCO/Secondary Cataract,Rt Eye
;;^UTILITY(U,$J,358.3,32616,1,4,0)
;;=4^H26.491
;;^UTILITY(U,$J,358.3,32616,2)
;;=^5005358
;;^UTILITY(U,$J,358.3,32617,0)
;;=E11.3292^^128^1665^16
;;^UTILITY(U,$J,358.3,32617,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32617,1,3,0)
;;=3^DM2 w/ Mild NPDR w/o Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,32617,1,4,0)
;;=4^E11.3292
;;^UTILITY(U,$J,358.3,32617,2)
;;=^5138336
;;^UTILITY(U,$J,358.3,32618,0)
;;=E11.3291^^128^1665^17
;;^UTILITY(U,$J,358.3,32618,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32618,1,3,0)
;;=3^DM2 w/ Mild NPDR w/o Macular Edema,Rt Eye
;;^UTILITY(U,$J,358.3,32618,1,4,0)
;;=4^E11.3291
;;^UTILITY(U,$J,358.3,32618,2)
;;=^5138335
;;^UTILITY(U,$J,358.3,32619,0)
;;=E11.3392^^128^1665^18
;;^UTILITY(U,$J,358.3,32619,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32619,1,3,0)
;;=3^DM2 w/ Mod NPDR w/o Macular Edema,Lt Eye
;;^UTILITY(U,$J,358.3,32619,1,4,0)
;;=4^E11.3392
;;^UTILITY(U,$J,358.3,32619,2)
;;=^5138344
;;^UTILITY(U,$J,358.3,32620,0)
;;=E11.3391^^128^1665^19
;;^UTILITY(U,$J,358.3,32620,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,32620,1,3,0)
;;=3^DM2 w/ Mod NPDR w/o Macular Edema,Rt Eye
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI21M 3805 printed Nov 22, 2024@17:30:11 Page 2
IBDEI21M ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,32608,1,3,0)
+2 ;;=3^Exudative AMD,Rt Eye
+3 ;;^UTILITY(U,$J,358.3,32608,1,4,0)
+4 ;;=4^H35.3210
+5 ;;^UTILITY(U,$J,358.3,32608,2)
+6 ;;=^5138520
+7 ;;^UTILITY(U,$J,358.3,32609,0)
+8 ;;=H35.3220^^128^1665^29
+9 ;;^UTILITY(U,$J,358.3,32609,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,32609,1,3,0)
+12 ;;=3^Exudative AMD,Lt Eye
+13 ;;^UTILITY(U,$J,358.3,32609,1,4,0)
+14 ;;=4^H35.3220
+15 ;;^UTILITY(U,$J,358.3,32609,2)
+16 ;;=^5138524
+17 ;;^UTILITY(U,$J,358.3,32610,0)
+18 ;;=R51.^^128^1665^31
+19 ;;^UTILITY(U,$J,358.3,32610,1,0)
+20 ;;=^358.31IA^4^2
+21 ;;^UTILITY(U,$J,358.3,32610,1,3,0)
+22 ;;=3^Headache
+23 ;;^UTILITY(U,$J,358.3,32610,1,4,0)
+24 ;;=4^R51.
+25 ;;^UTILITY(U,$J,358.3,32610,2)
+26 ;;=^5019513
+27 ;;^UTILITY(U,$J,358.3,32611,0)
+28 ;;=H20.00^^128^1665^32
+29 ;;^UTILITY(U,$J,358.3,32611,1,0)
+30 ;;=^358.31IA^4^2
+31 ;;^UTILITY(U,$J,358.3,32611,1,3,0)
+32 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
+33 ;;^UTILITY(U,$J,358.3,32611,1,4,0)
+34 ;;=4^H20.00
+35 ;;^UTILITY(U,$J,358.3,32611,2)
+36 ;;=^5005133
+37 ;;^UTILITY(U,$J,358.3,32612,0)
+38 ;;=H02.204^^128^1665^33
+39 ;;^UTILITY(U,$J,358.3,32612,1,0)
+40 ;;=^358.31IA^4^2
+41 ;;^UTILITY(U,$J,358.3,32612,1,3,0)
+42 ;;=3^Lagophthalmos,Unspec,Lt Upper Eyelid,Unspec
+43 ;;^UTILITY(U,$J,358.3,32612,1,4,0)
+44 ;;=4^H02.204
+45 ;;^UTILITY(U,$J,358.3,32612,2)
+46 ;;=^5004330
+47 ;;^UTILITY(U,$J,358.3,32613,0)
+48 ;;=H02.201^^128^1665^34
+49 ;;^UTILITY(U,$J,358.3,32613,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,32613,1,3,0)
+52 ;;=3^Lagophthalmos,Unspec,Rt Upper Eyelid,Unspec
+53 ;;^UTILITY(U,$J,358.3,32613,1,4,0)
+54 ;;=4^H02.201
+55 ;;^UTILITY(U,$J,358.3,32613,2)
+56 ;;=^5004327
+57 ;;^UTILITY(U,$J,358.3,32614,0)
+58 ;;=H40.053^^128^1665^35
+59 ;;^UTILITY(U,$J,358.3,32614,1,0)
+60 ;;=^358.31IA^4^2
+61 ;;^UTILITY(U,$J,358.3,32614,1,3,0)
+62 ;;=3^Ocular Hypertension,Bilateral
+63 ;;^UTILITY(U,$J,358.3,32614,1,4,0)
+64 ;;=4^H40.053
+65 ;;^UTILITY(U,$J,358.3,32614,2)
+66 ;;=^5005742
+67 ;;^UTILITY(U,$J,358.3,32615,0)
+68 ;;=H26.492^^128^1665^36
+69 ;;^UTILITY(U,$J,358.3,32615,1,0)
+70 ;;=^358.31IA^4^2
+71 ;;^UTILITY(U,$J,358.3,32615,1,3,0)
+72 ;;=3^PCO/Secondary Cataract,Lt Eye
+73 ;;^UTILITY(U,$J,358.3,32615,1,4,0)
+74 ;;=4^H26.492
+75 ;;^UTILITY(U,$J,358.3,32615,2)
+76 ;;=^5005359
+77 ;;^UTILITY(U,$J,358.3,32616,0)
+78 ;;=H26.491^^128^1665^37
+79 ;;^UTILITY(U,$J,358.3,32616,1,0)
+80 ;;=^358.31IA^4^2
+81 ;;^UTILITY(U,$J,358.3,32616,1,3,0)
+82 ;;=3^PCO/Secondary Cataract,Rt Eye
+83 ;;^UTILITY(U,$J,358.3,32616,1,4,0)
+84 ;;=4^H26.491
+85 ;;^UTILITY(U,$J,358.3,32616,2)
+86 ;;=^5005358
+87 ;;^UTILITY(U,$J,358.3,32617,0)
+88 ;;=E11.3292^^128^1665^16
+89 ;;^UTILITY(U,$J,358.3,32617,1,0)
+90 ;;=^358.31IA^4^2
+91 ;;^UTILITY(U,$J,358.3,32617,1,3,0)
+92 ;;=3^DM2 w/ Mild NPDR w/o Macular Edema,Lt Eye
+93 ;;^UTILITY(U,$J,358.3,32617,1,4,0)
+94 ;;=4^E11.3292
+95 ;;^UTILITY(U,$J,358.3,32617,2)
+96 ;;=^5138336
+97 ;;^UTILITY(U,$J,358.3,32618,0)
+98 ;;=E11.3291^^128^1665^17
+99 ;;^UTILITY(U,$J,358.3,32618,1,0)
+100 ;;=^358.31IA^4^2
+101 ;;^UTILITY(U,$J,358.3,32618,1,3,0)
+102 ;;=3^DM2 w/ Mild NPDR w/o Macular Edema,Rt Eye
+103 ;;^UTILITY(U,$J,358.3,32618,1,4,0)
+104 ;;=4^E11.3291
+105 ;;^UTILITY(U,$J,358.3,32618,2)
+106 ;;=^5138335
+107 ;;^UTILITY(U,$J,358.3,32619,0)
+108 ;;=E11.3392^^128^1665^18
+109 ;;^UTILITY(U,$J,358.3,32619,1,0)
+110 ;;=^358.31IA^4^2
+111 ;;^UTILITY(U,$J,358.3,32619,1,3,0)
+112 ;;=3^DM2 w/ Mod NPDR w/o Macular Edema,Lt Eye
+113 ;;^UTILITY(U,$J,358.3,32619,1,4,0)
+114 ;;=4^E11.3392
+115 ;;^UTILITY(U,$J,358.3,32619,2)
+116 ;;=^5138344
+117 ;;^UTILITY(U,$J,358.3,32620,0)
+118 ;;=E11.3391^^128^1665^19
+119 ;;^UTILITY(U,$J,358.3,32620,1,0)
+120 ;;=^358.31IA^4^2
+121 ;;^UTILITY(U,$J,358.3,32620,1,3,0)
+122 ;;=3^DM2 w/ Mod NPDR w/o Macular Edema,Rt Eye
